Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

GEMSP: a new therapeutic approach to multiple sclerosis.

Geffard M, Duleu S, Bessede A, Vigier V, Bodet D, Mangas A, Covenas R.

Cent Nerv Syst Agents Med Chem. 2012 Sep;12(3):173-81. Review.

PMID:
22533511
2.

Endotherapia: a new frontier in the treatment of multiple sclerosis and other chronic diseases.

Geffard M, de Bisschop L, Duleu S, Hassaine N, Mangas A, Coveñas R.

Discov Med. 2010 Nov;10(54):443-51.

3.

A new drug candidate (GEMSP) for multiple sclerosis.

Mangas A, Coveñas R, Bodet D, Duleu S, Geffard M.

Curr Med Chem. 2009;16(25):3203-14. Epub 2009 Sep 1. Review.

PMID:
19548873
4.

Follow-up of multiple sclerosis patients treated with Endotherapia (GEMSP).

Geffard M, Mangas A, Coveñas R.

Biomed Rep. 2017 Mar;6(3):307-313. doi: 10.3892/br.2017.857. Epub 2017 Feb 9.

5.

Evaluation of the effects of a new drug candidate (GEMSP) in a chronic EAE model.

Mangas A, Coveñas R, Bodet D, de León M, Duleu S, Geffard M.

Int J Biol Sci. 2008 May 22;4(3):150-60.

6.

New drug therapies for multiple sclerosis.

Mangas A, Coveñas R, Geffard M.

Curr Opin Neurol. 2010 Jun;23(3):287-92. doi: 10.1097/WCO.0b013e32833960f6. Review.

PMID:
20414110
7.
8.

Multiple sclerosis: immune mechanism and update on current therapies.

Bansil S, Cook SD, Rohowsky-Kochan C.

Ann Neurol. 1995 May;37 Suppl 1:S87-101. Review.

PMID:
8968220
9.
10.

Antigen-specific therapies in MS - Current concepts and novel approaches.

Lutterotti A, Sospedra M, Martin R.

J Neurol Sci. 2008 Nov 15;274(1-2):18-22. doi: 10.1016/j.jns.2008.05.021. Epub 2008 Jul 3. Review.

PMID:
18599087
12.

MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

Thamilarasan M, Koczan D, Hecker M, Paap B, Zettl UK.

Autoimmun Rev. 2012 Jan;11(3):174-9. doi: 10.1016/j.autrev.2011.05.009. Epub 2011 May 18. Review.

PMID:
21621006
13.
14.

Treatment of autoimmune disease by oral tolerance to autoantigens.

Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N.

Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S31-9. Review.

PMID:
8811061
15.

Antigen-specific therapies in multiple sclerosis.

Sospedra M, Martin R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):393-413. Review.

PMID:
16318988
16.
17.
18.
19.

Multiplexing approaches for autoantibody profiling in multiple sclerosis.

Somers K, Govarts C, Stinissen P, Somers V.

Autoimmun Rev. 2009 Jun;8(7):573-9. doi: 10.1016/j.autrev.2009.02.001. Epub 2009 Feb 9. Review.

PMID:
19393211
20.

The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications.

Archelos JJ, Hartung HP.

Mol Med Today. 1997 Jul;3(7):310-21. Review.

PMID:
9257299

Supplemental Content

Support Center